26
Views
9
CrossRef citations to date
0
Altmetric
Review

A guide to lymphedema

&
Pages 741-752 | Published online: 10 Jan 2014

References

  • Moffatt CJ, Franks PJ, Doherty DC et al. Lymphoedema: an underestimated health problem. Q. J. Med.96, 731–738 (2003).
  • Földi M. Insufficiency of lymph flow. In: Lymphangiology. Földi M, Casley-Smith JR (Eds). Schatteuer, Stuttgart, Germany, 195–213 (1983).
  • Tiwari A, Myint F, Hamilton G. Management of lower limb lymphoedema in the United Kingdom. Eur. J. Vasc. Endovasc. Surg.31(3), 311–315 (2006).
  • Smeltzer DM, Stickler GB, Schirger A. Primary lymphedema in children and adolescents: a follow-up study and review. Pediatrics76(2), 206–218 (1985).
  • Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. Q. J. Med.98(5), 343–348 (2005).
  • Mortimer PS, Levick JR. Chronic peripheral oedema: the critical role of the lymphatic system. Clin. Med.4(5), 448–453 (2004).
  • Kubik S, Manestar M. Anatomy of the lymph capillaries and precollectors of the skin. In: The Initial Lymphatics. Bollinger A, Partsch H, Wolfe JJN (Eds). Thieme, Stuttgart, Germany, 66–74 (1985).
  • De Long TG, Simmons RL. Role of lymphatic vessels in bacterial clearance from early soft tissue infection. Arch. Surg.117, 123–128 (1982).
  • Yoffey JM, Courtice JM. Lymphatics, Lymph and the Lymphomyeloid Complex. New York Academic Press, NY, USA (1970).
  • Karkkainen MJ, Haiko P, Sainio K et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol.5(1), 74–80 (2004).
  • Witte MH, Erickson R, Bernas M et al. Phenotypic and genotypic heterogeneity in familial Milroy lymphedema. Lymphology31(4), 145–155 (1998).
  • Ferrell RE, Levinson KL, Esman JH et al. Hereditary lymphedema: evidence for linkage and genetic heterogeneity. Hum. Mol. Genet.7(13), 2073–2078 (1998).
  • Evans AL, Brice G, Sotirova V et al. Mapping of primary congenital lymphedema to the 5q35.3 region. Am. J. Hum. Genet.64(2), 547–555 (1999).
  • Karkkainen MJ, Ferrell RE, Lawrence EC et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat. Genet.25, 153–159 (2000).
  • Butler MG, Dagenais SL, Rockson SG et al. A novel VEGFR3 mutation causes Milroy disease. Am. J. Med. Genet. A.143(11), 1212–1217 (2007).
  • Brice G, Mansour S, Bell R et al. Analysis of the phenotypic abnormalities in lymphoedema distichiasis syndrome in 74 patients with FOXC-2 mutations or linkage to 16q.24. J. Med. Genet.39, 478–483 (2000).
  • Fang J, Dagenais SL, Erikson RP et al. Mutations in FOXC-2 (MFH-1) a forkhead family transcription factor are responsible for hereditary lymphedema-distichiasis syndrome. Am. J. Hum. Genet.67, 1382–1388 (2000).
  • Finegold DN, Kimak MA, Lawrence EC et al. Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum. Mol. Genet.10(11), 1185–1189 (2001).
  • Kriederman BM, Myloyde TL, Witte MH et al.FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome. Hum. Mol. Genet.12(10), 1179–1185 (2003).
  • Sholto-Douglas-Vernon C, Bell R, Brice G et al. Lymphoedema-distichiasis and FOXC2, unreported mutations, de novo mutation estimate, families without coding mutations. Hum. Genet.117(2–3), 238–242 (2005).
  • Meige H. Dystrophie oedemateuse héréditaire. Presse Méd.6, 341–343 (1898).
  • Zhou XP, Hampel H, Thiele H et al. Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndrome. Lancet358, 210–211 (2001).
  • Mortimer PS. Disorders of lymphatic vessels. In: Rook’s Textbook of Dermatology (7th Edition). Burns DA, Breathnach SM, Cox NH, Griffiths CEM (Eds). Blackwell Publishing, Oxford, UK (2004).
  • Cox NH. Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow up. Br. J. Dermatol.155(5), 947–950 (2006).
  • Stoberl C, Partsch H. Erysipelas and lymphoedema: hen or egg? Hautkrankheiten62, 56–62 (1987).
  • de Almeida AB, Freedman DO. Epidemiology and immunopathology of bancroftian filariasis. Microbes Infect.1(12), 1015–1022 (1999).
  • Kiely PD, Bland JM, Joseph AE et al. Upper limb lymphatic function in inflammatory arthritis. J. Rheumatol.22, 214–217 (1995).
  • Nagai Y, Aoyama K, Endo Y et al. Lymphedema of the extremities developed as the initial manifestation of rheumatoid arthritis. Eur. J. Dermatol.17(2), 175–176 (2007).
  • Sakorafas GH, Peros G, Cataliotti L et al. Lymphedema following axillary lymph node dissection for breast cancer. Surg. Oncol.15(3), 153–165 (2006).
  • Sneddon I, Church R. Practical Dermatology (4th Edition). Edward Arnold, London, UK, 166 (1983).
  • Mortimer PS. Managing lymphoedema. Clin. Exp. Dermatol.20, 98–106 (1995).
  • Stemmer R. Ein klinisches Zeichen zur Früh-und Differentialdiagnose des Lymphödems. Vasa5, 261–262 (1976).
  • International Society of Lymphology. The diagnosis and treatment of peripheral lymphoedema. Consensus document of the International Society of Lymphology. Lymphology36(2), 84–91 (2003).
  • Wheatley DC, Wastie ML, Whitaker SC et al. Lymphoscintigraphy and colour Doppler sonography in the assessment of leg oedema of unknown cause. Br. J. Radiol69, 1117–1124 (1996).
  • Kinmonth JB. Lymphangiography in man. Clin. Sci.11, 13–20 (1952).
  • Stewart G, Gaunt J. Croft DN et al. Isotope lymphography: a new method of investigating the role of lymphatics. Br. J. Surg.72, 906–909 (1985).
  • Proby CM, Gane JN, Joseph AE et al. Investigation of the swollen limb with isotope lymphography. Br. J. Dermatol.123, 29–38 (1990).
  • Lymphoedema Framework. Best practice for the management of lymphoedema, international consensus. MEP Ltd, London, UK (2006).
  • Allen EU, Hines EA. Lipoedema of the legs. A syndrome characterized by fat legs and orthostatic oedema. Proc. Staff Mayo Clinic15, 1984–1987 (1940).
  • Wold LE, Hines EA, Allen EV. Lipoedema of the legs. Ann. Intern. Med.34, 1243–1250 (1949).
  • Amann-Vesti BR, Franzeck UK, Bollinger A. Microlymphatic aneurysms in patients with lipedema. Lymphology34(4), 170–175 (2001).
  • Harwood CA, Bull RH, Evans J et al. Lymphatic and venous function in lipoedema. Br. J. Dermatol.134, 1–6 (1996).
  • Beninson J, Edelglass JW. Lipedema – the non-lymphatic masquerader. Angiology35(8), 506–510 (1984).
  • Ketterings C. Lipodystrophy and its treatment. Ann. Plast. Surg.21(6), 536–543 (1988).
  • Jager G, Doller W, Roth R. Quality-of-life and body image impairments in patients with lymphedema. Lymphology39(4), 193–200 (2006).
  • Pyszel A, Malyszczak K, Pyszel K et al. Disability, psychological distress and quality of life in breast cancer survivors with arm lymphoedema. Lymphology39(4), 185–192 (2006).
  • Vignes S, Dupuy A. Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study. J. Eur. Acad. Dermatol. Venereol.20(7), 818–822 (2006).
  • Stewart FW, Treves N. Lymphangiosarcoma in postmastectomy lymphoedema. Cancer1, 64–81 (1948).
  • Laskas JJ, Shelley WB, Wood MG. Lymphangiosarcoma arising in congenital lymphedema. Arch. Dermatol.111(1), 86–89 (1975).
  • Offori TW, Platt CC, Stephens M et al. Angiosarcoma in congenital hereditary lymphoedema (Milroy’s disease) – diagnostic beacons and a review of the literature. Clin. Exp. Dermatol.18(2), 174–177 (1993).
  • Dürr HR, Pellengahr C, Nerlich A et al. Stewart–Treves syndrome as a rare complication of a hereditary lymphedema. Vasa33(1), 42–45 (2004).
  • Taghian A, de Vathaire F, Terrier P et al. Long-term risk of sarcoma following radiation treatment for breast cancer. Int. J. Radiat. Oncol. Biol. Phys.21(2), 361–367 (1991).
  • Peyron N, Dandurand M, Guillot B. Malignant tumors as complications of lymphedema. J. Mal. Vasc.18(4), 293–298 (1993).
  • Grobmyer SR, Daly JM, Glotzbach RE et al. Role of surgery in the management of postmastectomy extremity angiosarcoma (Stewart–Treves syndrome). J. Surg. Oncol.73(3), 182–188 (2000).
  • Abraham JA, Hornicek FJ, Kaufman AM et al. Treatment and outcome of 82 patients with angiosarcoma. Ann. Surg. Oncol.14(6), 1953–1967 (2007).
  • Benson PM, Pessoa CM, Lupton GP et al. Basal cell carcinomas arising in chronic lymphoedema. J. Dermatol. Surg. Oncol.14, 781–783 (1988).
  • Epstein JL, Mendelsohn G. Squamous carcinoma of the foot arising in association with longstanding verrucous hyperplasia in a patient with congential lymphoedema. Cancer54, 943–947 (1984).
  • Hills RJ, Ive FA. Cutaneous secondary follicular centre cell lymphoma in association with lymphoedema praecox. Br. J. Dermatol.129, 186–189 (1993).
  • Bartal AH, Pinsky CM. Malignant melanoma appearing in a postmastectomy lymphoedematous arm: a novel association of double primary tumours. J. Surg. Oncol.30, 16–18 (1985).
  • Merimsky O, Chaitchik S. Kaposi’s sarcoma on a lymphoedematous arm following radical mastectomy. Tumori78, 407–408 (1992).
  • Shreiber H, Barry FM, Russell WC et al. Stewart–Treves syndrome: a lethal complication of post mastectomy lymphoedema and regional immune deficiency. Arch. Surg.114, 82–85 (1979).
  • Franks PJ, Moffatt CJ, Doherty DC et al. Assessment of health-related quality of life in patients with lymphedema of the lower limb. Wound Repair Regen.14(2), 110–118 (2006).
  • Foldi E, Foldi M, Weissleder H. Conservative treatment of lymphoedema of the limbs. Angiology36, 171–180 (1985).
  • Cheville Al, McGarvey CL, Petrek JA et al. Lymphedema management. Semin. Radiat. Oncol.13(3), 290–301 (2003).
  • Badger CMA, Peacock JL, Mortimer PS. A randomized, controlled, parallel group clinical trial comparing multi-layer bandaging followed by hosiery versus hosiery alone in the treatment of patients with lymphoedema of the limb. Cancer88, 2832–2837 (2000).
  • Clark M, Krimmel G. Lymphoedema and the construction and classification of compression hosiery. In: Lymphoedema Framework. Template for Practice: Compression Hosiery in Lymphoedema. MEP Ltd, London, UK, 2–4 (2006).
  • Marston W, Vowden K. Compression therapy: a guide to safe practice. In: European Wound Management Association (EWMA). Position Document: Understanding Compression Therapy. MEP Ltd, London, UK, 11–17 (2003).
  • Szuba A, Achalu R, Rockson SG. Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema. A randomized, prospective study of a role for adjunctive intermittent pneumatic compression. Cancer95(11), 2260–2267 (2002).
  • Ikomi F, Schmid-Schonbein GW. Lymph transport in the skin. Clin. Dermatol.13, 419–427 (1995).
  • Mortimer PS, Simmonds R, Rezvani M et al. Measurement of skin lymph flow by an isotope clearance technique: reliability, reproducibility effect of injection dynamics and lymph flow enhancement. J. Invest. Dermatol.95, 677–682 (1990).
  • Mortimer PS, Badger C, Clarke I, Pallett J. A double blind randomized, parallel group, placebo-controlled trial of O-(-β hydroxyethyl)-rutosides in chronic arm oedema resulting from breast cancer treatment. Phlebology10, 51–55 (1995).
  • Loprinzi CL, Kugler JW, Sloan JA et al. Lack of effect of coumarin in women with lymphoedema after treatment for breast cancer. N. Eng. J. Med.340, 346–350 (1999).
  • Sistrunk WE. Modification of the operation for elephantiasis. JAMA71, 800 (1918).
  • Charles H. A System of Treatment Latham , English TC (Eds). Churchill, London, UK (1912).
  • Gloviczki P. Principles of surgical treatment of chronic lymphoedema. Int. Angiol.18(1), 42–46 (1999).
  • Carrell T, Burnand K. Surgery and lymphoedema. In: Lymphoedema. Twycross R, Jenns K, Todd J (Eds). Radcliffe Medical Press, Oxford, UK, 285–292 (2000).
  • Goldsmith HS, De los Santos R, Beattie GJ. Relief of chronic lymphoedema by omental transportation. Ann Surg.166, 573–585 (1967).
  • Pugnaire MR. Linfangioplastia mesenterica en el tratamiento de las elephantiasis de las membros inferiors. Angiologia20, 146–152 (1968).
  • Kinmonth JB. The Lymphatics: Surgery, Lymphography and Diseases of the Chyle and Lymph Systems. Edward Arnold, London, UK (1982).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.